ANDREA JACOBS-STANNARD: Open Payments
NPI 1295852440 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,650 in 57 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $116 · 2025 $1,650
Food & beverage: $1,650
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 12 | $357 |
| Journey Medical Corporation | 3 | $288 |
| Organon LLC | 3 | $126 |
| UCB, Inc. | 4 | $124 |
| Amgen Inc. | 4 | $108 |
| Incyte Corporation | 4 | $107 |
| Botanix SB Inc | 2 | $97 |
| PFIZER INC. | 5 | $87 |
| Galderma Laboratories, L.P. | 5 | $80 |
| ABBVIE INC. | 3 | $59 |
Products named: ADBRY, EMROSI, ANZUPGO, Bimzelx, OTEZLA, OPZELURA, SOFDRA, CIBINQO.
Industry payments across CT — which companies pay providers there.
